Lumida
/CV
⌘K
CV

CV

CV
$5.97USD+0.67%+0.04 today

MARKET CAP

298.8M

P/E (TTM)

FWD P/E

DAY RANGE

$6 – $6

52W RANGE

$3
$15

AI Summary

Stalk
TrimMedium

CV remains in a Stage 4 downtrend with supply dominating demand and price trading below all EMAs at the 5.80–5.87 support cluster. Oversold conditions on the RSI suggest a potential bounce that could disrupt bearish timing. Medium-term directional asymmetry is bearish, so deferred sell engagements into the 5.97–6.54 resistance zone are preferred over immediate selling.

  • Q2 2026 revenue $3.64M (+9.9% YoY); H2 sales expected higher
  • AI Highlights feature targets FDA clearance by end of Q3 2026
  • Q2 2026 net loss $7.48M (+62% YoY); EPS -$0.15 missed forecast
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2025TREND
Sales, Adj.$13.6M
YoY %
P / Sales19.4x
EV / Sales19.0x
Gross Profit, Adj.$7.2M
YoY %
Margin %52.9%
EV / Gross Profit35.9x
EBITDA, Adj.$-24.9M
YoY %
Margin %-184.1%
EV / EBITDA-10.3x
EBIT$-25.5M
YoY %
Margin %-188.3%
EV / EBIT-10.1x
Net Income$-25.3M
YoY %
Net Margin-186.8%
EPS (GAAP)-$1.03
YoY %